IRIS
ORIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.129
EU - Europa 11.548
AS - Asia 6.227
SA - Sud America 963
Continente sconosciuto - Info sul continente non disponibili 496
AF - Africa 93
OC - Oceania 25
Totale 44.481
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.843
RU - Federazione Russa 3.497
UA - Ucraina 2.810
VN - Vietnam 1.840
CN - Cina 1.830
SG - Singapore 1.802
GB - Regno Unito 1.214
SE - Svezia 1.116
DE - Germania 1.029
BR - Brasile 756
FR - Francia 605
IT - Italia 542
FI - Finlandia 342
KR - Corea 129
CA - Canada 126
PL - Polonia 124
IN - India 104
HK - Hong Kong 86
BD - Bangladesh 80
AR - Argentina 62
EU - Europa 62
IQ - Iraq 59
NL - Olanda 47
VE - Venezuela 37
JP - Giappone 36
TR - Turchia 36
CO - Colombia 35
MX - Messico 30
IL - Israele 29
SA - Arabia Saudita 29
BE - Belgio 28
PK - Pakistan 28
EC - Ecuador 26
AT - Austria 24
ES - Italia 24
LV - Lettonia 24
UZ - Uzbekistan 22
ZA - Sudafrica 21
AU - Australia 19
IE - Irlanda 19
PH - Filippine 19
CR - Costa Rica 17
ID - Indonesia 17
HN - Honduras 15
MA - Marocco 15
TT - Trinidad e Tobago 15
JM - Giamaica 14
SC - Seychelles 14
TN - Tunisia 12
CL - Cile 11
DK - Danimarca 11
GT - Guatemala 11
PY - Paraguay 11
PE - Perù 10
PR - Porto Rico 10
PT - Portogallo 10
SV - El Salvador 10
BG - Bulgaria 9
CZ - Repubblica Ceca 9
NI - Nicaragua 9
BO - Bolivia 8
JO - Giordania 8
KE - Kenya 8
MY - Malesia 8
AZ - Azerbaigian 7
HU - Ungheria 7
AE - Emirati Arabi Uniti 6
BY - Bielorussia 6
EG - Egitto 6
GP - Guadalupe 6
HR - Croazia 6
LT - Lituania 6
OM - Oman 6
PA - Panama 6
RS - Serbia 6
AL - Albania 5
BH - Bahrain 5
EE - Estonia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
CW - ???statistics.table.value.countryCode.CW??? 4
HT - Haiti 4
KG - Kirghizistan 4
RO - Romania 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
KW - Kuwait 3
LU - Lussemburgo 3
MM - Myanmar 3
NO - Norvegia 3
NP - Nepal 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BN - Brunei Darussalam 2
CY - Cipro 2
DZ - Algeria 2
GD - Grenada 2
Totale 44.006
Salva come PNG Salva come JPEG
Città #
Fairfield 2.739
Woodbridge 2.587
Houston 1.978
Ashburn 1.958
Dong Ket 1.474
Ann Arbor 1.448
Chandler 1.364
Wilmington 1.317
San Jose 1.270
Seattle 1.088
Dallas 1.018
Cambridge 933
Dearborn 890
Jacksonville 780
Singapore 670
Southend 630
Nyköping 614
Boardman 475
Moscow 428
Beijing 379
Council Bluffs 291
Princeton 270
Lawrence 258
The Dalles 208
Ogden 178
Düsseldorf 137
Los Angeles 136
Shanghai 127
Ho Chi Minh City 124
Des Moines 115
Phoenix 115
Kraków 108
Hanoi 94
Yubileyny 90
San Diego 89
Hutchinson 88
São Paulo 87
Helsinki 82
Bremen 75
Hong Kong 75
Santa Clara 74
New York 73
Grafing 66
Nanjing 62
Jinan 55
London 55
Chicago 50
Hefei 40
Englewood 38
Brooklyn 35
Tokyo 34
Frankfurt am Main 33
Rome 32
Toronto 29
Edinburgh 28
Norwalk 28
Brussels 27
Naples 27
Shenyang 27
Amsterdam 26
North Bergen 26
Kunming 24
Munich 24
Riga 24
San Mateo 24
Baghdad 23
Da Nang 23
Montreal 23
Guangzhou 22
Napoli 21
Nanchang 20
Rio de Janeiro 20
Belo Horizonte 19
Tashkent 19
Atlanta 18
Auburn Hills 18
Milan 18
Chennai 17
Hanover 17
Zhengzhou 17
Boston 16
Buffalo 16
Mirabella Eclano 16
Taiyuan 16
Charlotte 15
Hangzhou 15
Curitiba 14
Dublin 14
Kilburn 14
Lake Worth 14
San José 14
Vienna 14
Hebei 13
Riyadh 13
San Francisco 13
Tianjin 13
Brasília 12
Changsha 12
Columbus 12
Falls Church 12
Totale 28.321
Salva come PNG Salva come JPEG
Nome #
Il microinfusore: quali indicazioni e quando iniziare 476
Sussidio didattico per gli studenti di igiene generale e applicata per il corso di laurea in scienze del servizio sociale 338
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 310
Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity 276
Effects of physical exercise on the female reproductive system. 268
The good and bad effects of statins on insulin sensitivity and secretion 257
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 253
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. 252
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. 252
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance 247
Cardiopulmonary impairment in young women with polycystic ovary syndrome. 247
Secrezioni ormonali ectopiche 244
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. 241
Endocrine secretions under abnormal light-dark cycles and in the blind. 235
The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome 235
A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. 234
Vitamin D and thyroid disease: to D or not to D? 234
Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside. 233
Cardiological aspects of growth hormone and insulin-like growth factor-I. 232
Failure of long-term therapy with sodium valproate in Cushing's disease. 225
Liver-spleen axis, Insulin-like Growth Factor-(IGF)-I axis and fat mass in overweight/obese females 225
Height, weight, height velocity of primary school population sample in Campania region. 225
Adiponectin levels in women with polycystic ovary syndrome 219
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. 218
Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response 218
Effects of neridronate treatment in elderly women with osteoporosis 217
Bisphenol A in Polycystic Ovary Syndrome and its Association with Liver-Spleen Axis. 217
Lifestyle changes in the management of adulthood and childhood obesity. 215
Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood and quality of life 214
Adrenal mass: insight into pathogenesis and a common link with insulin resistance. 214
THE IMPACT OF PROBAND GLUCOSE TOLERANCE STATUS ON BODY MASS INDEX (BMI) AND ADIPOSITY IN ADOLESCENT GIRLS AT HIGH RISK FOR POLYCYSTIC OVARY SYNDROME (PCOS) 213
Ovulation induction in polycystic ovary syndrome 213
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 213
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 213
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 212
Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens. 211
Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome? 211
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 211
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine. 209
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. 209
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 208
Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. 207
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS 207
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. 206
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology. 206
Effect of growth hormone on cardiac function. 205
Auditory brainstem responses in thyroid diseases before and after therapy. 205
Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005 205
Is the ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? 205
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis. 204
Thyroid function and morphology after a successful kidney transplantation 204
The increase of leukocytes as a new putative marker of low- grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome 204
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome. 204
Adrenocortical tumors and insulin resistance. What is the first step? 204
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin 203
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review 203
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women. 202
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. 202
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 202
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women 201
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 201
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. 201
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept. 201
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome 200
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 200
Growth hormone status in morbidly obese subjects and correlation with body composition 199
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 199
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. 199
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors 198
Cardiovascular risk of women with polycystic ovary syndrome 198
Anti-proliferative and pro-apoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women 197
Circulating ghrelin concentrations in the polycystic ovary syndrome 197
Endothelial dysfunction in PCOS: role of obesity and adipose hormones. 197
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 197
Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. 196
Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study 196
Antisperm antibodies in cryptorchidism before and after surgery. 196
Terapia di associazione con insulina ed analoghi del GLP-1 196
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 196
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 196
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. 195
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women 195
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 195
Current evidence on vitamin D deficiency and kidney transplant: What’s new? 195
Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age 194
Does raloxifene inhibit the growth of uterine fibroids? 194
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 194
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 192
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome 192
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 191
Evidence for altered adipocyte function in polycystic ovary syndrome. 191
GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding. 191
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome:A Prospective Parallel Randomized Double-Blind Placebo-Controlled Trial 191
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 191
Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial 189
Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis 189
Pervasive developmental disorders in children of hyperandrogenic women with polycystic ovary syndrome: a longitudinal case-control study. 189
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 188
Lymphocyte subset pattern in acromegaly. 188
Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study 188
Totale 21.465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 177.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.807
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022905 0 0 0 0 76 45 253 199 141 116 69 6
2022/20234.290 523 136 215 458 498 796 115 566 571 120 223 69
2023/20241.231 134 71 77 54 54 34 25 316 268 56 12 130
2024/20255.948 86 505 15 133 86 499 1.693 2.000 322 199 205 205
2025/20266.434 491 820 523 413 413 163 988 645 948 710 173 147
2026/20272.239 127 131 808 1.165 8 0 0 0 0 0 0 0
Totale 44.481